Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
[Effects of serum components of patients with liver diseases on hepatocyte cytotoxicity and plasminogen activator production of activated macrophages]. [electronic resource] by
- Sawai, H
- Mizoguchi, Y
- Tsutsui, H
- Miyazima, Y
- Ikemoto, Y
- Arai, T
- Sakagami, Y
- Higashimori, T
- Monna, T
- Yamamoto, S
Producer: 19831220
In:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology vol. 80
Availability: No items available.
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
β-Galactosidase treatment is a common first-stage modification of the three major subtypes of Gc protein to GcMAF. [electronic resource] by
- Uto, Yoshihiro
- Yamamoto, Syota
- Mukai, Hirotaka
- Ishiyama, Noriko
- Takeuchi, Ryota
- Nakagawa, Yoshinori
- Hirota, Keiji
- Terada, Hiroshi
- Onizuka, Shinya
- Hori, Hitoshi
Producer: 20120807
In:
Anticancer research vol. 32
Availability: No items available.
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
|